FDA Warns PhytoCeuticals For Adulterated Cosmetics, Cancer Claims
This article was originally published in The Rose Sheet
Agency’s most recently posted warning letters to skin-care marketers include one to PhytoCeuticals for adulterated cosmetics, following an inspection of the company’s manufacturing facility. Osea Internacional and Face Naturals also draw warnings for claims that identify their products as unapproved drugs.
You may also be interested in...
Ads claiming P&G's Olay Regenerist skin-care line “re-energizes skin’s appearance cell by cell” mislead consumers into expecting deeper cellular changes rather than mere surface exfoliation, an implied benefit unsupported by the firm's evidence, according to the UK’s independent regulator.
Inspections conducted over the past year may have contributed to a wider FDA crackdown on unapproved sunscreen drug products – specifically those in dosage forms deemed ineligible under OTC drug review for inclusion in the sunscreen monograph – with five marketers targeted so far this month with warning letters.
Agency inspectors observed a range of insanitary conditions and practices at the Blacksburg, Virginia-based manufacturing site that turns out Bioque and Vouray skin-care products, causing the products to be adulterated, according to an FDA warning letter.